Literature DB >> 6986115

Comparison of cefamandole, cephalothin, ampicillin, and chloramphenicol in experimental Escherichia coli meningitis.

T R Beam, J C Allen.   

Abstract

The activities of cefamandole, cephalothin, ampicillin, and chloramphenicol were compared in fulminant and temperate Escherichia coli meningitis in rabbits. Intensive dosing schedules were employed to achieve maximal therapeutic benefits with short-term treatment. In an 8-h schedule chloramphenicol was significantly more effective in sterilizing the cerebrospinal fluid and curing both fulminant and temperate infections than cefamandole or ampicillin. Cephalothin was without effect in fulminant meningitis. Cefamandole and ampicillin were equivalent in activity in this and longer (12- and 24-hr) treatment schedules. The therapeutic benefits of chloramphenicol were purchased via use of doses above those generally regarded as safe for human use. The mean serum, cerebrospinal fluid, and brain concentrations of chloramphenicol, cefamandole, and ampicillin were significantly greater in rabbits with fulminant meningitis than in those with temperate meningitis. The difference was of such magnitude as to support the need to monitor drug concentrations.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6986115      PMCID: PMC283723          DOI: 10.1128/AAC.17.1.37

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

1.  Concentrations of bacteria in cerebrospinal fluid of patients with bacterial meningitis.

Authors:  W E Feldman
Journal:  J Pediatr       Date:  1976-04       Impact factor: 4.406

2.  Blood, brain, and cerebrospinal fluid concentrations of several antibiotics in rabbits with intact and inflamed meninges.

Authors:  T R Beam; J C Allen
Journal:  Antimicrob Agents Chemother       Date:  1977-12       Impact factor: 5.191

3.  The rate of bacteriologic response to antimicrobial therapy in neonatal meningitis.

Authors:  G H McCracken
Journal:  Am J Dis Child       Date:  1972-06

4.  Antibiotic penetration of the brain. A comparative study.

Authors:  P W Kramer; R S Griffith; R L Campbell
Journal:  J Neurosurg       Date:  1969-09       Impact factor: 5.115

5.  Cefamandole and ampicillin therapy in experimental Haemophilus influenzae meningitis.

Authors:  L J Strausbaugh; C D Mandaleris; M A Sande
Journal:  J Infect Dis       Date:  1977-02       Impact factor: 5.226

6.  High-performance liquid chromatographic assay of chloramphenicol in serum.

Authors:  J R Koup; B Brodsky; A Lau; T R Beam
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

7.  Cephalothin and cephaloridine therapy for bacterial meningitis.

Authors:  L S Fisher; A W Chow; T T Yoshikawa; L B Guze
Journal:  Ann Intern Med       Date:  1975-05       Impact factor: 25.391

8.  The paradox of Hemophilus infuenzae type B bacteremia in the presence of serum bactericidal activity.

Authors:  S Shaw; A L Smith; P Anderson; D H Smith
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

9.  Chloramphenicol pharmacokinetics in hospitalized patients.

Authors:  J R Koup; A H Lau; B Brodsky; R L Slaughter
Journal:  Antimicrob Agents Chemother       Date:  1979-05       Impact factor: 5.191

  9 in total
  6 in total

1.  Bactericidal activity of cefoperazone with CP-45,899 against large inocula of beta-lactamase-producing Haemophilus influenzae.

Authors:  P K Yu; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1981-07       Impact factor: 5.191

Review 2.  Cephalosporins in adult meningitis.

Authors:  T R Beam
Journal:  Bull N Y Acad Med       Date:  1984-05

3.  Paradox between the responses of Escherichia coli K1 to ampicillin and chloramphenicol in vitro and in vivo.

Authors:  K S Kim; M Manocchio; B F Anthony
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

4.  Pharmacokinetics and bacteriological efficacy of cefoperazone, ceftriaxone, and moxalactam in experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis.

Authors:  G H McCracken; J D Nelson; L Grimm
Journal:  Antimicrob Agents Chemother       Date:  1982-02       Impact factor: 5.191

5.  Trimethoprim-sulfamethoxazole therapy of experimental Escherichia coli meningitis in rabbits.

Authors:  J M Mylotte; T R Bates; K A Sergeant; R E Matson; T R Beam
Journal:  Antimicrob Agents Chemother       Date:  1981-07       Impact factor: 5.191

6.  Potential value of cefoperazone in bacterial meningitis: experimental studies.

Authors:  D T Durack; J R Perfect
Journal:  Drugs       Date:  1981       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.